Acyl-CoA:Cholesterol Acyltransferase Inhibition Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice

Circulation - United States
doi 10.1161/01.cir.103.21.2604
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Deficiency of Acyl CoA:cholesterol Acyltransferase 2 Prevents Atherosclerosis in Apolipoprotein E-Deficient Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

597. Therapy of Atherosclerosis in Apolipoprotein E-Deficient Mice

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Inhibition of Endoplasmic Reticulum Stress and Atherosclerosis by 2-Aminopurine in Apolipoprotein E-Deficient Mice

ISRN Pharmacology
2013English

Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Paradoxical Enhancement of Atherosclerosis by Probucol Treatment in Apolipoprotein E-Deficient Mice.

Journal of Clinical Investigation
Medicine
1997English

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice

Mediators of Inflammation
ImmunologyCell Biology
2014English

Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice

Scientific Reports
Multidisciplinary
2019English

Atherosclerosis: The Apolipoprotein E-Deficient Mouse Model Revisited

Microscopy and Microanalysis
Instrumentation
2002English

Association of Multiple Cellular Stress Pathways With Accelerated Atherosclerosis in Hyperhomocysteinemic Apolipoprotein E-Deficient Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy